Conference
Final analysis of overall survival for the Phase III CONFIRM trial: fulvestrant 500 mg versus 250 mg
| العنوان: | Final analysis of overall survival for the Phase III CONFIRM trial: fulvestrant 500 mg versus 250 mg |
|---|---|
| المؤلفون: | DI LEO, Angelo, JERUSALEM, Guy, PETRUZELKA, Lubos, TORRES, Roberto, BONDARENKO, Igor N., KHASANOV, Rustem, VERHOEVEN, Didier, PEDRINI, José L., SMIRNOVA, Iva, LICHINITSER, Mikhail R., PENDERGRASS, Kelly, GARNETT, Sally, RUKAZENKOV, Yuri, MARTIN, Miguel |
| المصدر: | Cancer Research. Supplement, 72 (24), S1-4 (2012-12-15); San Antonio Breast Cancer Symposium, San Antonio, United States [US], 4-8 December, 2012 |
| بيانات النشر: | University of Chicago Press, 2012. |
| سنة النشر: | 2012 |
| مصطلحات موضوعية: | Human health sciences, Oncology, Sciences de la santé humaine, Oncologie |
| نوع الوثيقة: | conference paper http://purl.org/coar/resource_type/c_5794 conferenceObject peer reviewed |
| اللغة: | English |
| Relation: | urn:issn:0576-6656 |
| URL الوصول: | https://orbi.uliege.be/handle/2268/156154 |
| Rights: | restricted access http://purl.org/coar/access_right/c_16ec info:eu-repo/semantics/restrictedAccess |
| رقم الانضمام: | edsorb.156154 |
| قاعدة البيانات: | ORBi |
| الوصف غير متاح. |